In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... then you’ll have a lot of winners with ...

Seeking Alpha's Quant system consistently outperforms the S&P 500 ( SP500 ), driven by powerful computer processing and SA's ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... ll have a lot of winners with these drug and medical device plays.” For this article, we compiled a list ...

US-based pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven ...

N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...

GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely ...

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

The healthcare space is a great place to look for these sorts of players because here you'll find all that you need to gain ...

Vineet Gupta, Associate Vice President and Managing Director of India and Alliances at Eli Lilly, spoke with Business Today about the company's ... process for other device options is still ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.